ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Onward to 2010? NCI promises faster progress for more money.

May 20, 2005

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011